New combo therapy aims to outsmart liver Cancer's hiding spots
NCT ID NCT04862949
Summary
This study looked at whether a combination of two drugs (atezolizumab and bevacizumab) could better control advanced liver cancer, especially tumors located in the liver itself. Researchers tested this in 131 patients with advanced liver cancer who had not yet received other drug treatments. The main goal was to see if the treatment worked differently on cancer in the liver versus cancer that had spread to other organs.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ADVANCED HEPATOCELLULAR CARCINOMA are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Cha Medical Center
Seongnam-si, Gyeonggi-do, 13496, South Korea
Conditions
Explore the condition pages connected to this study.